All content for Talking Urology Podcast is the property of Talking Urology and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Damien Bolton & Andrew Weickhardt discuss ‘The COVID conundrum: loss and lessons learned.
ANZUP 2019 Interviews - Andrew Weickhardt chats with Betsy Plimack, genetic mutations in bladder ca
Talking Urology Podcast
10 minutes 7 seconds
6 years ago
ANZUP 2019 Interviews - Andrew Weickhardt chats with Betsy Plimack, genetic mutations in bladder ca
In this ANZUP conference highlight, Andrew Weickhardt chats with Betsy Plimack, Chief of the Division of Genitourinary Medical Oncology, Fox Chase Cancer Centre in the US. She talks about the future potential role of genetic mutations in urothelial cancer: can they predict response to treatments or even decide which treatments you should use? They also discuss the use of the new immuno-oncology agents in metastatic kidney cancer: what are the second line options, and how do we measure success of treatments- keep a close ear out for the emerging concept of treatment free survival as the yard stick for the immune-oncology agents.
Talking Urology Podcast
Damien Bolton & Andrew Weickhardt discuss ‘The COVID conundrum: loss and lessons learned.
